BioNTech is a German biotechnology company at the forefront of developing innovative immunotherapies, leveraging mRNA technology to combat cancer and infectious diseases. Founded in 2008, the company is recognised for its groundbreaking contributions to personalised medicine and vaccine development.

Headquartered in Mainz, Germany, BioNTech combines cutting-edge research with advanced manufacturing to produce life-saving therapeutics. Its extensive expertise in mRNA technology, cell therapy, and antibody engineering drives its mission to revolutionise healthcare. BioNTech is globally renowned for its role in developing the COVID-19 vaccine in partnership with Pfizer.

Key Products and Services

• COVID-19 mRNA vaccines
• Personalised cancer immunotherapies
• Infectious disease vaccines
• Cell and gene therapy platforms
• mRNA-based oncology solutions

With a strong commitment to innovation, BioNTech continues to transform lives worldwide through precision medicine and advanced biotechnological solutions.